摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one | 123020-95-1

中文名称
——
中文别名
——
英文名称
1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one
英文别名
1-(2,4-dihydroxyphenyl)-2-phenyl-1-propanone;3-hydroxy-4-(1-oxo-2-phenylpropyl)phenol
1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one化学式
CAS
123020-95-1
化学式
C15H14O3
mdl
——
分子量
242.274
InChiKey
HGCKWBSCARPESJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    乙酸酐1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one4-二甲氨基吡啶 作用下, 生成 [3-Acetyloxy-4-(2-phenylpropanoyl)phenyl] acetate
    参考文献:
    名称:
    (±)-芳基烷基酮与天然和修饰的猪胰脂肪酶的对映选择性生物催化反应
    摘要:
    摘要 猪胰脂肪酶 (PPL) 在四氢呋喃中与苯乙酮预孵育,无法识别 (±)-2,4-二酰氧基苯基烷基酮中与核羰基相关的邻位和对位酰氧基官能团,并产生新的芳基烷基中等至高度旋光形式的酮类;这一结果支持了关于 PPL 在过酰化多酚的脱酰反应中的作用机制的假设。
    DOI:
    10.3109/10242421003734704
  • 作为产物:
    描述:
    7-羟基异黄酮 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 以60%的产率得到1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one
    参考文献:
    名称:
    α-甲基脱氧安息香素的合成
    摘要:
    在回流的THF中使用LiAlH 4还原羟基和/或甲氧基取代的异黄酮,可轻松获得大量α-甲基脱氧安息香素,可能是人体植物雌激素的代谢产物。的合成Ô -demethylangolensin 2b中,6'- hydroxyangolensin 2C,2D angolensin,1-(2,4-二羟基苯基)-2-苯基丙-1-酮2E,1-(2-羟基-4-甲氧基苯基)-2- (4-羟基苯基)丙烷-1-酮2f,4'- O-甲基血管紧张素2g,1-(2-羟基-4-甲氧基苯基)-2-苯基丙烷-1-酮2h和1-(2-羟基苯基)-描述了2-苯基丙烷-1-酮2i。
    DOI:
    10.1039/a904946k
点击查看最新优质反应信息

文献信息

  • Synthesis of Various Kinds of Isoflavones, Isoflavanes, and Biphenyl-Ketones and Their 1,1-Diphenyl-2-picrylhydrazyl Radical-Scavenging Activities
    作者:Hideyuki Goto、Yoshiyasu Terao、Shuji Akai
    DOI:10.1248/cpb.57.346
    日期:——
    Forty-eight kinds of isoflavones (8), thirty-one isoflavanes (9), and forty-seven biphenyl-ketones (10, 10′) were synthesized from eleven kinds of substituted phenols (11) and six phenylacetic acids (12). Among them, seventy-five compounds are new. The radical scavenging activities of these compounds were evaluated using 1,1-diphenyl-2-picrylhydrazyl (DPPH) at pH 6.0. We found that thirty-nine out of forty-three compounds having a catechol moiety on either the A- or the B-ring exhibited a high activity (ED50=12—54 μM) similar to that of catechin. In these cases, the remaining part of their structure seemed to have little effect on their activity. Many 6- or 8-hydroxyisoflavanes (9E—I) and their biphenyl-ketone derivatives (10E—H) also showed a high activity (ED50=<50 μM), while all of their corresponding isoflavones (8E—I) were not active at all. The 7-hydroxyisoflavanes having either an additional hydroxyl group at the C5-position (9D) or a methoxy group at the C6-position (9J) presented a high activity (ED50=26—32 μM). This study suggests that natural isoflavones have the possibilities of exhibiting antioxidant activities through the hydroxylation at the C6-, C8-, or C3′-position or the formation of the isoflavanes (9) and/or the biphenyl-ketone derivatives (10′) by metabolism or biotransformation.
    合成了四十八种异黄酮(8)、三十一种异黄烷(9)以及四十七种联苯酮(10, 10′),这些化合物是由十一种取代酚(11)和六种苯乙酸(12)合成的。其中,有七十五种化合物是新发现的。这些化合物的自由基清除活性在pH 6.0下使用1,1-二苯基-2-吡唑啉酮(DPPH)进行了评估。我们发现,在四十三种含有儿茶酚基的化合物中,三十九种在A环或B环上表现出与儿茶素相似的高活性(ED50=12—54 μM)。在这些情况下,它们结构的其他部分似乎对活性影响不大。许多6-或8-羟基异黄烷(9E—I)及其联苯酮衍生物(10E—H)也显示出高活性(ED50=<50 μM),而它们对应的异黄酮(8E—I)则完全没有活性。具有在C5位增加羟基(9D)或在C6位增加甲氧基(9J)的7-羟基异黄烷则展现出高活性(ED50=26—32 μM)。本研究表明,天然异黄酮通过在C6、C8或C3′位置的羟基化,或通过代谢或生物转化形成异黄烷(9)和/或联苯酮衍生物(10′),具有表现抗氧化活性的可能性。
  • Optically active compound and chiral liquid crystal composition
    申请人:Nippon Telegraph and Telephone Corporation
    公开号:US05059345A1
    公开(公告)日:1991-10-22
    An optically active compound represented by the general formula (I) of: R--Z--COO--(Ph).sub.k --Ph(Y)--CO--(CH.sub.2).sub.m C*HE L (1) In the general formula (I); R is an alkyl or alkoxy group having 4 to 22 carbon atoms; Z is the one selected from the group consisting of --Ph--, --Ph(X)--, --Ph--Ph--, Ph(X)--Ph--, --Ph--cy--, --Ph(X)--cy-- and --py--Ph-- is a 1,4-substituted phenylene group; --Ph--Ph-- is a 4,4'-substituted diphenylene group; --cy-- is a trans-1,4-cyclohexane group, --py is 2,5-substituted pyrimide group; X is a halogen atom at the ortho-position to R; k is zero or 1, Y is the one selected from the group consisting of H, OH, halogen atoms and methyl group; C* is an asymmetric carbon atom; E is the one selected from the group consisting of methyl group, halogen atoms and CF.sub.3 ; L is an alkyl, aryl or aralkyl group having not more than 10 carbon atoms; and m is an integer of zero to 6 where m takes zero when Y is H and Z is --Ph-- or --Ph--Ph--. The optically active compound is usable as an ingredient for a liquid crystal composition which has high spontaneous polarization, exhibits the Sc* phase (chiral smectic C liquid crystalline phase) in a wide temperature range and high speed response.
    通用公式(I)表示的具有光学活性的化合物为:R--Z--COO--(Ph).sub.k --Ph(Y)--CO--(CH.sub.2).sub.m C*HE L(1)。在通用公式(I)中;R是具有4到22个碳原子的烷基或烷氧基;Z是从--Ph--,--Ph(X)--,--Ph--Ph--,Ph(X)--Ph--,--Ph--cy--,--Ph(X)--cy--和--py--Ph--组成的组中选择的一个,其中--Ph--是1,4-取代苯基;--Ph--Ph--是4,4'-取代二苯基基团;--cy--是反-1,4-环己烷基团,--py是2,5-取代嘧啶基团;X是在R的邻位上的卤原子;k为零或1,Y是从H,OH,卤原子和甲基组成的组中选择的一个;C*是一个不对称碳原子;E是从甲基组,卤原子和CF.sub.3组成的组中选择的一个;L是具有不超过10个碳原子的烷基,芳基或芳基烷基;m是一个从零到6的整数,当Y为H且Z为--Ph--或--Ph--Ph--时,m取零。这种具有光学活性的化合物可用作具有高自发极化性的液晶组合物的成分,表现出在广泛温度范围内和高速响应中的Sc*相(手性各向异性C液晶相)。
  • Waehaelae, K.; Hase, T. A., Heterocycles, 1989, vol. 28, # 1, p. 183 - 186
    作者:Waehaelae, K.、Hase, T. A.
    DOI:——
    日期:——
  • Optically active compound and chiral liquid crystal composition containing the same
    申请人:NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    公开号:EP0315193B1
    公开(公告)日:1994-04-06
  • US5059345A
    申请人:——
    公开号:US5059345A
    公开(公告)日:1991-10-22
查看更多

同类化合物

安哥拉紫檀素 2-羟基-3-苯基苯丙酮 1-(2,4-二羟基苯基-3,5-d2)-2-(4-羟基苯基-3,5-d2)丙烷-1-酮-2-d1 1-(2,4-二羟基苯基)-2-(4-羟基苯基)丙-1-酮 1-(1-羟基萘-2-基)-2-甲基-2-苯基丙烷-1-酮 1-(2-hydroxy-5-methylphenyl)-3-(naphthalen-1-yl)-2-phenylpropan-1-one 2,4,5,4'-tetramethoxy-α-methyldesoxybenzoin 1-[2-(1-hydroxynaphthyl)]-2-phenyl-1-propanone 1-(4-(cyc lohexyloxy)-2-methoxyphenyl)-2-(3,4-dimethoxyphenyl)propan-1-one 2-(3,4-dimethoxyphenyl)-1-(4-hydroxy-2-methoxyphenyl)propan-1-one 1-(2-Hydroxy-4-methoxyphenyl)-2-(4-hydroxyphenyl)propan-1-one 1-(2-methoxyphenyl)-2-phenylpropan-1-one 2-(2-fluorophenyl)-1-(2-methoxy-4-(piperidin-1-yl)phenyl)propan-1-one (-)-angolensin (-)-angolensin-4-methyl ether 1-(2-methoxyphenyl)-2-phenyl-2-(trimethylsilyloxy)propan-1-one 1-(2,5-dimethoxy-4-methylphenyl)-2-phenylpropan-1-one (+/-)-1-<2,5-Dimethyl-phenyl>-2-phenyl-propan-1-on 1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)-[1,2,3-(13)C3]propan-1-one 1,2-bis(2-hydroxybenzoyl)-1-propanone 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)-2-methylpropan-1-one (+/-)-2-<2,4-Bis(methoxymethoxy)phenyl>-1-<2-hydroxy-4-(methoxymethoxy)phenyl>propan-1-on 1-(2-hydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one 1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 1-(2-hydroxy-4-methoxyphenyl)-2-(4-methoxyphenyl)-2-methylpropan-1-one 1-(2-hydroxy-4-methoxyphenyl)-2-phenylpropan-1-one 1-(2-hydroxyphenyl)-2-(2-hydroxy-4-methoxyphenyl)-1-propanone 2-hydroxy-3,4-dimethoxy-α-C-methoxydesoxybenzoin (R)-2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one 2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one 1-(2,5-dihydroxy-4-methoxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone 1-(5-Bromo-2-hydroxyphenyl)-2-(2-nitrophenyl)propan-1-one 1-(2,5-dihydroxy-4-methoxyphenyl)-2-phenyl-1-propanone 1-(2,4-Dihydroxyphenyl)-2-phenylpropan-1-one 1-(2,3,4-trihydroxyphenyl)-2-phenyl-1-propanone (S)-2-(3,4-dimethoxyphenyl)-1-(5-methoxy-2,2-dimethyl-2H-chromen-6-yl)propan-1-one Ethyl 4-[1-[4-(dimethylamino)-2-hydroxyphenyl]-1-oxopropan-2-yl]benzoate 2-[[2-(2-Methyl-2-phenylpropanoyl)phenoxy]methoxy]propyl benzoate (2S)-1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one 1-[2,4-Bis(trimethylsiloxy)phenyl]-2-[(4-trimethylsiloxy)phenyl]propan-1-one 1-(2,4-dimethoxyphenyl)-2-(4-methoxyphenyl)propan-1-one (+/-)-Di-O-acetyl-angolensin 4'-hydroxy-2,4-dimethoxy-α-methyldeoxybenzoin 1-(2,3,4-dihydroxyphenyl)-2-(4'-hydroxyphenyl)-1-propanone 1-(2,4-Dihydroxyphenyl)-2-(3-hydroxy-4-methoxyphenyl)propan-1-one 2-(4-Methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one 1-(2,4-Dihydroxyphenyl)-2-(3,5-dimethoxyphenyl)propan-1-one 1-[4-[(1,6-dimethyl-4-propan-2-yl-3,4,4a,7,8,8a-hexahydro-2H-naphthalen-1-yl)oxy]-2-hydroxyphenyl]-2-(4-methoxyphenyl)propan-1-one 1-(2,4-Dihydroxy-5-methoxyphenyl)-2-(4-hydroxyphenyl)propan-1-one (+/-)-4-O-methylangolensin